# Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools

> **NCT05415904** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 101 (actual)

## Conditions studied

- Hantavirus Nephropathy
- Hantavirus Infection

## Interventions

- **OTHER:** HANTA-NE

## Key facts

- **NCT ID:** NCT05415904
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-20
- **Primary completion:** 2023-10-30
- **Final completion:** 2024-07-31
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05415904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05415904, "Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05415904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*